Allogene Therapeutics Inc (ALLO)
2.09
+0.14
(+7.18%)
USD |
NASDAQ |
Dec 24, 16:00
Allogene Therapeutics Market Cap: 438.21M for Dec. 24, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
ANI Pharmaceuticals Inc | 1.138B |
AIM ImmunoTech Inc | 12.04M |
Perspective Therapeutics Inc | 217.97M |
Protalix BioTherapeutics Inc | 130.33M |
Armata Pharmaceuticals Inc | 73.09M |
Market Cap Related Metrics
PS Ratio | 4425.08 |
Price to Book Value | 0.9449 |
Price | 2.09 |
Earnings Yield | -74.64% |